leg pain on semaglutide Ozempic: Weight Loss Drugs May Help Reduce Knee Dermal Hypersensitivity Reaction to Semaglutide:

Once you stop injecting or taking semaglutide orally, your body no longer receives these signals, and appetite typically returns to baseline levels

It is not approved by Health Canada for human or veterinary use

While GLP-1 receptors are present in the hippocampus and preclinical studies suggest potential cognitive benefits, there is currently no FDA-approved indication for GLP-1 medications in cognitive disorders or neuroprotection

Glucagon receptor-mediated effects introduce additional considerations: Potential for transient increases in heart rate (also observed with GLP-1R agonists) Theoretical risk of hyperglycaemia from glucagon signalling, though phase 2 trial data suggest this is counterbalanced by concurrent GLP-1R and GIPR agonism In phase 2 trials, the most commonly reported adverse events were gastrointestinal in nature, consistent with the class

Transient headache or light-headedness following administration